1. Map and observe
Document a real recurring task, its required information, decision owner, exceptions and existing manual process. Establish a baseline and limit data access to what is authorized.
AURYVETH Knowledge / Planned validation
Why AURYVETH intends to test its organisms inside AURYVETH first.
Before asking another organization to rely on a business organism, AURYVETH plans to use the architecture for its own recurring work. Internal operation offers a way to observe failures, improve recovery and measure usefulness while keeping external customer risk out of the initial proving ground.
Proposed sequence
Prove a narrow operational loop before widening the scope.
2. Prepare work
Have the organism produce a reviewable draft or recommendation. Keep consequential execution inside explicitly granted authority, preserve evidence and record corrections.
3. Compare outcomes
Measure accepted and corrected work, missed exceptions, time, recovery and evidence quality against the baseline. Record failure cases as well as successes.
4. Consider narrow authority
Review whether a defined low-risk action can be authorized within explicit policy, monitoring and evidence requirements. Retain an escalation path and the ability to revoke authorization.
What evidence is required?
Versioned task definitions, environment and test conditions, operator corrections, exception rates, outcome records and documented limitations. A useful experiment should also say what would count against the hypothesis.
A single polished demonstration is not a substitute for repeatable evidence over relevant work cycles. Acceptance criteria and thresholds must be fixed before seeing the result rather than weakened afterward to produce a pass.
Current evidence boundary
This page does not report completed deployment, customer adoption, autonomous revenue or performance results. The sequence is a planned evaluation method. Research results will be published separately when recorded and supportable.
AURYVETH intends to keep proposed architecture, experimental findings and production capability visibly distinct.
Why begin with internal validation?
It places organizational memory, approval flow and recovery under direct observation. An architecture that cannot reliably support AURYVETH’s own approved work under its frozen governance and acceptance rules should not be marketed as proven for broader deployment.
For the technical context, read Business Organisms, the authority model, the roadmap and research direction.